Press Releases - 2021-08-26

Date	Title	Company
26-Aug-2021	Sales of Linear Accelerators Devices for Radiotherapy Is Expected to Gain Steadfast Traction, Procuring an Annual Growth of More than US$ 1.9 Bn	MARKITWIRED Latest Market Reports
26-Aug-2021	OTC Herbal and Traditional Medicines Sales In Online OTC Channel Is Expected To Register the Fastest Expansion	MARKITWIRED Latest Market Reports
26-Aug-2021	North America’s Demand for C-kit/CD117 Tests Is Anticipated to Account for Nearly US$ 800 Mn In Revenues by 2022-end	MARKITWIRED Latest Market Reports
26-Aug-2021	Quotient Sciences Announces Multimillion-Pound Investment in Drug Substance Manufacturing Facility	Quotient Sciences
26-Aug-2021	Achilles Therapeutics Announces Grant of US and European Patents	Achilles Therapeutics
26-Aug-2021	HUTCHMED Initiates a Phase Ib/II Trial of Fruquintinib in Combination with Tislelizumab in Advanced Triple Negative Breast Cancer or Advanced Endometrial Cancer	HUTCHMED
26-Aug-2021	A new study in Argentina on Sputnik V: “Our observations suggest that protection increases over 6 months following vaccination as a consequence of antibody maturation, resulting in improved potency of antibodies to viral escape mutations.”	Russian Direct Investment Fund
26-Aug-2021	Moderna Completes Submission of Biologics License Application to the U.S. Food and Drug Administration for its COVID-19 Vaccine	Moderna
26-Aug-2021	Spinal Muscular Atrophy Treatment Market Witnesses Static Increase in Patent Filings Since 2015: Sagacious IP	Sagacious IP
26-Aug-2021	Asklepios Kliniken: Coronavirus pandemic still having an impact in H1 2021	Asklepios Kliniken
26-Aug-2021	Evolva accelerated revenue growth to 60% and expects gross profit to be positive from Q4, 2021	Evolva Holding SA
26-Aug-2021	Philippe Deecke appointed as Chief Financial Officer of Lonza Group	Lonza Group AG
26-Aug-2021	Biotest AG: Biotest receives approval for phase III clinical trial in pregnant women for prevention of CMV infection of the unborn baby	Biotest AG